The first 15 minutes of hemodialysis does not affect platelets

Haematologia

Volumn 28, Issue 1, 1996, Pages 41-44

  Komarnicki, M ^a   Kazmierczak M ^a   De Mezer Dambek, M ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Ambulatory Centre of Hemodialysis   (Poland)

Author keywords

Glycoproteins; Hemodialysis; Platelet; Uremia

Indexed keywords

ADULT; ARTICLE; BLOOD; CHRONIC DISEASE; HUMAN; MIDDLE AGED; PATHOLOGY; RENAL REPLACEMENT THERAPY; THROMBOCYTE; TIME; UREMIA;

ADULT; BLOOD PLATELETS; CHRONIC DISEASE; HUMANS; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; UREMIA;

EID: 2842593748     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hakim, R. M., Schafer, A. T.: Hemodialysis-associated platelet activation and thrombocytopenia. Am. J. Med. 78, 575 (1985).
2. Andrássy, K., Ritz, E., Bommer, J.: Effects of hemodialysis on platelets. Contr. Nephrol. 59, 26 (1987).
3. Brandt, P., Jespersen, J., Sorensen, L. H.: Antithrombin-III and platelets in hemodialysis patients. Nephron 28, 1 (1981).
4. Vicks, S. L., Gross, M. L., Schmitt, G. W.: Massive hemorrhage due to hemodialysis-associated thrombocytopenia. Am. J. Nephrol. 3, 30 (1983).
5. Docci, D., Turci, F., Del-Vecchio, C., Bilancioni, R., Cenciotti, L., Pretolani, E.: Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry. Int. J. Artif. Organs 7, 337 (1984).
6. Jacob, A. I., Gavellas, G., Zarco, R., Perez, G., Bourgoingnie, J. J.: Leukopenia, hypoxia, and complement function with different hemodialysis membranes. Kidney Int. 18, 505 (1980).
7. Stein, G., Gunther, K., Sperschneider, H., Carlsohn, H., Huller, M., Schubert, K., Schaller, R.: Clinical evaluation of a new dialyzer, FLX-12 GW, with a polyester-polymer alloy membrane. Artif. Organs 17, 339 (1993).
8. Michelson, A. D.: Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Blood Coagulation and Fibrinolysis 5, 121 (1994).
9. Sreedhara, R., Itagaki, I., Lynn, B., Hakim, R. M.: Defective platelet aggregation in uremia is transiently worsened by hemodialysis. Am. J. Kidney Dis. 25, 555 (1995).
10. Chong, B. H., Ismail, F.: The mechanism of heparin-induced platelet aggregation. Eur. J. Haematol. 43, 245 (1989).
11. Chong, B. H.: Heparin-induced thrombocytopenia. Blood Rev. 2, 108 (1988).
12. Zachee, P., Vermylen, J., Boogaerts, M. A.: Hematologic aspects of end-stage renal failure. Ann. Hematol. 69, 33 (1994).
13. Burstein, A., Ishibashi, T.: Erythropoietin and megakaryocytopoiesis. Blood Cells 15, 193 (1989).
14. Akizawa, T., Kinugasa, E., Kitaoka, T., Koshikawa, S.: Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients. Nephron. 58, 400 (1991).